J.M. 1987a. Intraoperative radiotherapy of carcinoma of the prostate gland in ten dogs. J Am Vet Med Assoc 190:48–52.
706 Turrel, J.M. 1987b. Principles of radiation therapy. In Veterinary Cancer Medicine. G.H. Thielen and B.R. Madewell, editors. Philadelphia: Lea and Febiger.
707 Turrel, J.M., B.E. Kitchell, L.M. Miller, et al. 1988. Prognostic factors for radiation treatment of mast cell tumor in 85 dogs. J Am Vet Med Assoc 193:936–940.
708 Turrel, J.M., M.C. McEntee, B.P. Burke, et al. 2006. Sodium iodide I 131 treatment of dogs with nonresectable thyroid tumors: 39 cases (1990–2003). J Am Vet Med Assoc 229:542–548.
709 Upton, M.L., C.H. Tangner, and M.E. Payton. 2006. Evaluation of carbon dioxide laser ablation combined with mitoxantrone and piroxicam treatment in dogs with transitional cell carcinoma. J Am Vet Med Assoc 228:549–552.
710 U'ren, L.W., B.J. Biller, R.E. Elmslie, et al. 2007. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma. J Vet Intern Med 21:113–120.
711 Vail, D.M. 2007. Plasma cell tumors. In Withrow & MacEwen’s Small Animal Clinical Oncology, 4th edition. S.J. Withrow and D.M. Vail, editors. St. Louis: Saunders.
712 Vail, D.M., A.E. Hershey, and A.S. Moore. 2000. Efficacy of adjuvant inhalational chemotherapy following surgical cytoreduction in dogs with spontaneously arising node positive primary lung cancer. In Proceedings Annual Meeting of American Association for Cancer Research, San Francisco, (abstract 1272). Philadephia: American Association for Cancer Research.
713 Vail, D.M., E.G. MacEwen, I.D. Kurzman, et al. 1995. Liposome‐encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: A randomized multi‐institutional clinical trial. Clin Cancer Res 1:1165–1170.
714 Vail, D.M., B.E. Powers, D.M. Getzy, et al. 1994. Evaluation of prognostic factors for dogs with synovial sarcoma: 36 cases (1986–1991). J Am Vet Med Assoc 205:1300–1307.
715 Vail, D.M., H. Von Euler, A.W. Rusk, et al. 2012. A randomized trial investigating the efficacy and safety of water soluble micellar paclitaxel (Paccal Vet) for treatment of nonresectable grade 2 or 3 mast cell tumors in dogs. J Vet Intern Med 26:598–607.
716 Vail, D.M. and K.M. Young. 2007. Canine lymphoma and lymphoid leukaemia. In Withrow & MacEwen’s Small Animal Clinical Oncology, 4th edition. S.J. Withrow and D.M. Vail, editors. St. Louis: Saunders.
717 Valerius, K.D., G.K. Ogilvie, C.H. Mallinckrodt, et al. 1997a. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987–1995). J Am Vet Med Assoc 210:512–516.
718 Valerius, K.D., B.E. Powers, M.A. Mcpherron, et al. 1997b. Adenomatous polyps and carcinoma in situ of the canine colon and rectum: 34 cases (1982–1994). J Am Anim Hosp Assoc 33:156–160.
719 Van Der Kooij, M., I. Becvarova, H.P. Meyer, et al. 2014. Effects of an iodine‐restricted food on client‐owned cats with hyperthyroidism. J Feline Med Surg 16:491–498.
720 Van Ginkel, R.J., H.J. Hoekstra, F.J. Meutstege, et al. 1995. Hyperthermic isolated regional perfusion with cisplatin in the local treatment of spontaneous canine osteosarcoma: Assessment of short‐term effects. J Surg Oncol 59:169–176.
721 Van Lelyveld, S., J. Warland, R. Miller, et al. 2015. Comparison between Ki‐67 index and mitotic index for predicting outcome in canine mast cell tumours. J Small Anim Pract 56:312–319.
722 Vancil, J.M., C.J. Henry, R.J. Milner, et al. 2012. Use of samarium Sm 153 lexidronam for the treatment of dogs with primary tumors of the skull: 20 cases (1986–2006). J Am Vet Med Assoc 240:1310–1315.
723 Vasseur, P. 1987. Limb preservation in dogs with primary bone tumors. Vet Clin North Am Small Anim Pract 17:889–903.
724 Vaudaux, C., U. Schneider, and B. Kaser‐Hotz. 2007. Potential for intensity‐modulated radiation therapy to permit dose escalation for canine nasal cancer. Vet Radiol Ultrasound 48:475–481.
725 Venable, R.O., C.F. Saba, M.M. Endicott, et al. 2012. Dexrazoxane treatment of doxorubicin extravasation injury in four dogs. J Am Vet Med Assoc 240:304–307.
726 Venzin, C., S. Grundmann, and P. Montavon. 2012. Endoprosthesis (EN) in frontlimb‐sparing surgery for distal radial tumours in the dog: Preliminary results. Schweiz Arch Tierheilkd 154:337–343.
727 Villalobos, A. 2006. Dealing with chemotherapy extravasations: A new technique. J Am Anim Hosp Assoc 42:321–325.
728 Vincenti, S. and F. Findji. 2017. Influence of treatment on the outcome of dogs with incompletely excised grade‐2 mast cell tumors. Schweiz Arch Tierheilkd 159:171–177.
729 Von Euler, H., A. Sadeghi, B. Carlsson, et al. 2008. Efficient adenovector CD40 ligand immunotherapy of canine malignant melanoma. J Immunother 31:377–384.
730 Walker, M. and M. Breider. 1987. Intraoperative radiotherapy of canine bladder cancer. Vet Radiol 28:200–204.
731 Wallace, J., D.T. Matthiesen, and A.K. Patnaik. 1992. Hemimaxillectomy for the treatment of oral tumors in 69 dogs. Vet Surg 21:337–341.
732 Walter, C.U., W.S. Dernell, S.M. Larue, et al. 2005. Curative‐intent radiation therapy as a treatment modality for appendicular and axial osteosarcoma: A preliminary retrospective evaluation of 14 dogs with the disease. Vet Comp Oncol 3:1–7.
733 Waltman, S.S., B. Seguin, B.J. Cooper, et al. 2007. Clinical outcome of nonnasal chondrosarcoma in dogs: Thirty‐one cases (1986–2003). Vet Surg 36:266–271.
734 Wang, Z., W. Qiu, and W.M. Mendenhall. 2003. Influence of radiation therapy on reconstructive flaps after radical resection of head and neck cancer. Int J Oral Maxillofac Surg 32:35–38.
735 Ward, H., L.E. Fox, M.B. Calderwood‐Mays, et al. 1994. Cutaneous hemangiosarcoma in 25 dogs: A retrospective study. J Vet Intern Med 8:345–348.
736 Webster, J.D., V. Yuzbasiyan‐Gurkan, R.A. Miller, et al. 2007. Cellular proliferation in canine cutaneous mast cell tumors: Associations with c‐Kit and its role in prognostication. Vet Pathol 44:298–308.
737 Weisse, C. 2015. Veterinary interventional oncology: From concept to clinic. Vet J 205:198–203.
738 Weisse, C., A. Berent, K. Todd, et al. 2006. Evaluation of palliative stenting for management of malignant urethral obstructions in dogs. J Am Vet Med Assoc 229:226–234.
739 Weisse, C., C.A. Clifford, D. Holt, et al. 2002a. Percutaneous arterial embolization and chemoembolization for treatment of benign and malignant tumors in three dogs and a goat. J Am Vet Med Assoc 221:1430–1436, 1419.
740 Weisse, C., F.S. Shofer, and K. Sorenmo. 2002b. Recurrence rates and sites for grade II canine cutaneous mast cell tumors following complete surgical excision. J Am Anim Hosp Assoc 38:71–73.
741 Weisse, C., N. Soares, M.W. Beal, et al. 2005. Survival times in dogs with right atrial hemangiosarcoma treated by means of surgical resection with or without adjuvant chemotherapy: 23 cases (1986–2000). J Am Vet Med Assoc 226:575–579.
742 Wells, A.L., C.D. Long, W.J. Hornof, et al. 2001. Use of percutaneous ethanol injection for treatment of bilateral hyperplastic thyroid nodules in cats. J Am Vet Med Assoc 218:1293–1297.
743 Wendelburg, K.M., L.L. Price, K.E. Burgess, et al. 2015. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001–2012). J Am Vet Med Assoc 247:393–403.
744 Westberg, S., A. Sadeghi, E. Svensson, et al. 2013. Treatment efficacy and immune stimulation by AdCD40L gene therapy of spontaneous canine malignant melanoma. J Immunother 36:350–358.
745 White, R. 1991. Mandibulectomy and maxillectomy in the dog: Longterm survival in 100 cases. J Small Anim Pract 32:69–74.
746 White, R., M. Walker, A.M. Legendre, et al. 1990. Development of brachytherapy technique for nasal tumors in dogs. Am J Vet Res 51:1250–1256.
747 Wiley, J.L., K.A. Rook,